As we all know, excessive alcohol consumption can take a toll on our liver’s health, leading to the development of severe liver disorders including cirrhosis, alcoholic hepatitis, and ultimately, liver failure. Recent research discovered that there may be a potential solution to reduce the risk of liver failure caused by excessive drinking – probiotics.
Probiotics are live bacteria and yeast that are considered as friendly or good bacteria, which are found naturally in our body and digestive system. They can also be consumed through supplements or fermented foods such as yogurt, kefir, kombucha, and sauerkraut. Various studies have highlighted that probiotics can play a significant role in keeping our gut health in check, supporting our immune system, warding off harmful pathogens, alleviating inflammation, and even improving mental health.
But how exactly can probiotics help reduce the risk of liver failure caused by excessive drinking? According to a recent pilot study, researchers found that consuming Lactobacillus rhamnosus GG (LGG), one of the most commonly used probiotic strains, for 12 weeks, had a significant impact in reducing inflammation and liver enzymes in people who have a history of heavy drinking. These findings show that LGG may potentially serve as a protective agent against liver damage for those at risk of developing alcohol-related liver disease.
While further research is necessary to determine the beneficial effects of probiotics on liver disease, these findings offer promising insights into the potential benefits of probiotics in promoting liver health. Incorporating probiotics as part of a healthy diet may serve as a valuable addition to people looking to reduce the risks associated with excessive alcohol consumption. Consult with your doctor before starting any probiotic supplements.
Unfortunately, there is no statistical data available regarding the use of probiotics to reduce the risk of developing liver failure caused by excessive drinking. However, there is evidence that probiotics may be beneficial in reducing the risk of other liver diseases such as nonalcoholic fatty liver disease (NAFLD). A systematic review and metaanalysis published in 2019 found that probiotic supplementation was associated with a significant reduction in NAFLD risk compared to placebo (odds ratio 54; 95% CI 40–73). Additionally, a randomized controlled trial published in 2020 found that daily supplementation with a combination of probiotics and prebiotics for 12 weeks significantly reduced markers of liver injury and inflammation compared to placebo.